Overview

Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia

Status:
Completed

Trial end date:
2013-08-01

Target enrollment:

Participant gender:

Summary

This trial is a study on all-trans retinoic acid in combination with induction and consolidation therapy as well as pegfilgrastim after consolidation therapy in younger patients with newly diagnosed acute myeloid leukemia (AML).

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

University of Ulm

Treatments:

Cytarabine
Etoposide
Idarubicin
Tretinoin